Trial Profile
A Multicentre Study to Evaluate The Efficacy of Rituximab in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Russian Registry (Norma) Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jun 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Anti-neutrophil cytoplasmic antibody-associated vasculitis
- Focus Therapeutic Use
- Acronyms Norma project
- 22 Jun 2015 New trial record